Cardiology Update

DECEMBER 3, 2023

Dr. Chadi Alraies discusses highlights from the American Heart Association (AHA) Scientific Sessions 2023, which were held in Philadelphia, Pennsylvania (PA), on November 11-13, 2023. There were many important developments in presented in key clinical trial presentations and publications stemming from the AHA Scientific Sessions 2023. Learn more about AHA 2023 highlights.

Research 98

Research Cardio Oncology COVID-19 Heart Failure 98

CardiacWire

DECEMBER 3, 2023

In this Cardiac Wire Q&A, we sat down with AccurKardia CEO Juan C Jimenez and COO Mohamed Sadeq Ali to discuss ECG automation’s massive potential to improve clinical efficiency and care outcomes. Jimenez and Ali co-founded AccurKardia in 2019 with a vision for unlocking the value of the ECG signal, and the company currently markets one of the few FDA-cleared solutions for automated ECG interpretation and arrhythmia detection.

Arrhythmia 52

Arrhythmia Atrial Flutter Reimbursement Atrial Fibrillation 52

Heart Sisters

DECEMBER 3, 2023

by Carolyn Thomas ♥ @HeartSisters Have you ever had the same nightmare more than once about the same impossibly unlikely scenario? My own recurring nightmare: I’m walking into Mrs. Webster’s Grade 13 math class (Ontario high schools went up to Grade 13 in those days).

Heart Attack 52

Heart Attack Heart attacks Heart Disease 52

Journal of Cardiovascular Electrophysiology

DECEMBER 3, 2023

Abstract Introduction In patients with prior atrial septal defect (ASD) closure and atrial tachyarrhythmias, transseptal puncture can be challenging. Methods and Results This case report discusses a 65-year-old man who had previously undergone pulmonary vein isolation (PVI) and cavo-tricuspid isthmus ablation for atrial fibrillation before ASD closure, respectively.

Bicuspid/Mitral 40

Bicuspid/Mitral Ablation Aortic Atrial Fibrillation 40

ECG Weekly Workout

DECEMBER 3, 2023

This content is for members only

STEMI 74

STEMI 74

CardiacWire

DECEMBER 3, 2023

The left atrial appendage device space became far more competitive last week, following the launch of Medtronic’s Penditure LAA exclusion system and Johnson & Johnson MedTech’s acquisition of LAAX device company Laminar. Medtronic made waves across the LAA closure segment, announcing the FDA approval and limited commercial launch of its Penditure LAA exclusion system.

AFIB 52

AFIB Innovation Ablation 52